A detailed history of Point State Capital LP transactions in Amgen Inc stock. As of the latest transaction made, Point State Capital LP holds 63,517 shares of AMGN stock, worth $20.1 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
63,517
Holding current value
$20.1 Million
% of portfolio
0.51%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $16.7 Million - $20.3 Million
63,517 New
63,517 $19.8 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $2.73 Million - $3.03 Million
11,815 Added 100.0%
23,630 $5.75 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $2.73 Million - $3.03 Million
11,815 New
11,815 $2.88 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Point State Capital LP Portfolio

Follow Point State Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.